AstraZeneca Expected to Report Earnings of $2.60 per Share
An earnings preview expects AstraZeneca to post earnings of $2.60 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Citi sees Novo Nordisk sales slightly above consensus
Citi said Novo Nordisk's third-quarter sales could come in 1% above consensus, helped by a strong Wegovy pill launch in the U.K. The bank cut its target price to 296 kroner from 310 kroner and kept a neutral rating.
Insmed Q2 2026 Earnings Call Transcript
Insmed (NASDAQ: INSM ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Insmed reported strong
Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today
U.S. stocks are higher at midday Wednesday, led by technology and software shares, after softer-than-expected inflation data eased fears of another Federal Reserve rate hike. Oil is climbing again, however, and long-dated Treasury yields remain close to multi-decade highs. • United Therapeutics stock is charging ahead
Full Transcript: Sanofi Q2 2026 Earnings Call
Sanofi (NASDAQ: SNY ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Sanofi delivered a stro
Transcript: AstraZeneca Q2 2026 Earnings Conference Call
On Monday, AstraZeneca (NASDAQ: AZN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary AstraZeneca reported a 6% growth in total revenue for the fi